Dr. Jason Glazer, DMD Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 16 Main St, Suite 303, Durham, CT 06422 Phone: 860-712-7839 |
Amit Patel, DMD Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 28 Elihu Dr, Durham, CT 06422 Phone: 203-927-2104 |
Dr. Casey Lynn Foster, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 360 Main St, Durham, CT 06422 Phone: 860-349-1123 |
Dr. William J Witkowski, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 360 Main St # D, Durham, CT 06422 Phone: 860-349-1123 Fax: 860-349-2040 |
Dr. Allan A Witkowski, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 360 Main St # D, Durham, CT 06422 Phone: 860-349-1123 Fax: 860-349-2040 |
News Archive
A diverse collective of health care advocacy groups, patient organizations, industry representatives and other stakeholders today announced they have established the Alliance for Balanced Pain Management (AfBPM) to support appropriate access to integrated pain management and responsible use of prescription pain medicines with an aim to reduce abuse.
Cancer patients with low socioeconomic status (SES) have more advanced cancers at diagnosis, receive less aggressive treatment, and have a higher risk of dying in the five years following cancer diagnosis, according to a new study.
Systematic, progressive resistance training - also called strength training - is a safe and efficient way for middle-aged and older adults to improve their health. A Virginia Tech led research team that includes experts in behavior, exercise, physiology, and medicine is designing a program to help pre-diabetic adults begin and, most important, maintain resistance training in order to prevent diabetes.
A team of researchers from Osaka University, in cooperation with the Institute for Clinical Research and medical institutes participating in the Kansai Molecular Diagnosis Network for CNS Tumors, conducted the largest-ever retrospective cohort study for Japanese patients with glioblastoma, proposing an underlying prognosis biomarker responsible for the survival difference between two cohorts: an original Japanese cohort and a dataset from The Cancer Genome Atlas.
› Verified 8 days ago